AI assistant
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2006
Sep 6, 2006
30339_dirs_2006-09-06_17211d95-a7bb-4be0-b030-9e38c6576a30.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: WEST PHARMACEUTICAL SERVICES INC (wst)
CIK: 0000105770
Period of Report: 2005-03-07
Reporting Person: HARGESHEIMER ROBERT S (President - The Tech Group)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-03-07 | Common Stock | A | 2731.598 | — | Acquired | 21482.4402 | Direct |
| 2006-02-24 | Common Stock | A | 3928.168 | — | Acquired | 24997.6512 | Direct |
Footnotes
F1: Settlement for stock of Performance Rights that are non-derivative securities. See explanation below for further information.
F2: The Reporting Person was awarded 2,260 Performance Vesting Restricted (PVR) Shares on May 5, 2004 and 4,340 PVR Shares on June 29, 2004 for a total of 6,600 PVR Shares following the Company's 2004 stock split. The 2004 PVR Share Awards were inappropriately reported as restricted stock awards. In fact, the 2004 PVR Share Awards constituted performance rights that are non-derivative securities. As such, no reports should have been filed until the PVR Awards are settled in stock. Reporting the initial grant resulted in an overstatement of the amount of securities beneficially owned (Column 5, Table 1) in subsequently filed reports. The Reporting Person is filing this report to: (i) properly characterize the PVR Shares as performance rights; and (ii) adjust the amount of securities beneficially owned and eliminate the overstatement.
F3: Amount as of filing date.